SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.180
-0.010 (-0.84%)
Oct 31, 2024, 4:00 PM EDT - Market closed
SLS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Revenue | - | - | 1 | 7.6 | 1.9 | - | Upgrade
|
Revenue Growth (YoY) | - | - | -86.84% | 300.00% | - | - | Upgrade
|
Cost of Revenue | - | - | 0.1 | 0.2 | - | - | Upgrade
|
Gross Profit | - | - | 0.9 | 7.4 | 1.9 | - | Upgrade
|
Selling, General & Admin | 13.6 | 13.86 | 12.58 | 11.32 | 9.6 | 9.92 | Upgrade
|
Research & Development | 21.21 | 24.01 | 20.27 | 15.67 | 9.28 | 7.29 | Upgrade
|
Operating Expenses | 34.8 | 37.87 | 32.85 | 26.99 | 18.88 | 17.21 | Upgrade
|
Operating Income | -34.8 | -37.87 | -31.95 | -19.59 | -16.98 | -17.21 | Upgrade
|
Interest & Investment Income | 0.37 | 0.53 | 0.32 | 0.01 | 0.03 | 0.12 | Upgrade
|
Other Non Operating Income (Expenses) | - | 0 | 0.04 | 0.02 | -0.1 | 1.14 | Upgrade
|
EBT Excluding Unusual Items | -34.44 | -37.34 | -31.6 | -19.57 | -17.05 | -15.95 | Upgrade
|
Other Unusual Items | - | - | 0.3 | 4.34 | 0.28 | -0.59 | Upgrade
|
Pretax Income | -34.44 | -37.34 | -41.3 | -20.94 | -16.77 | -19.37 | Upgrade
|
Income Tax Expense | - | - | - | -0.24 | -0.02 | -0.08 | Upgrade
|
Net Income | -34.44 | -37.34 | -41.3 | -20.7 | -16.76 | -19.29 | Upgrade
|
Preferred Dividends & Other Adjustments | - | - | - | - | 0.08 | 8.66 | Upgrade
|
Net Income to Common | -34.44 | -37.34 | -41.3 | -20.7 | -16.84 | -27.95 | Upgrade
|
Shares Outstanding (Basic) | 40 | 28 | 19 | 15 | 8 | 3 | Upgrade
|
Shares Outstanding (Diluted) | 40 | 28 | 19 | 15 | 8 | 3 | Upgrade
|
Shares Change (YoY) | 73.24% | 43.21% | 25.29% | 94.07% | 211.76% | 878.33% | Upgrade
|
EPS (Basic) | -0.85 | -1.34 | -2.13 | -1.34 | -2.11 | -10.92 | Upgrade
|
EPS (Diluted) | -0.85 | -1.34 | -2.13 | -1.34 | -2.11 | -10.92 | Upgrade
|
Free Cash Flow | -32.16 | -31.41 | -23.81 | -26.02 | -10.42 | -17.64 | Upgrade
|
Free Cash Flow Per Share | -0.80 | -1.13 | -1.23 | -1.68 | -1.31 | -6.90 | Upgrade
|
Gross Margin | - | - | 90.00% | 97.37% | 100.00% | - | Upgrade
|
Operating Margin | - | - | -3195.00% | -257.82% | -893.79% | - | Upgrade
|
Profit Margin | - | - | -4130.10% | -272.36% | -886.05% | - | Upgrade
|
Free Cash Flow Margin | - | - | -2380.90% | -342.38% | -548.26% | - | Upgrade
|
EBIT | -34.8 | -37.87 | -31.95 | -19.59 | -16.98 | -17.21 | Upgrade
|
EBIT Margin | - | - | - | -257.82% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.